BAFF and APRIL are particularly relevant in MM, where BCMA and both soluble factors are augmented in samples from patients compared to healthy donors, and ligand–receptor interactions lead to increased survival of malignant cells (264–267). This evidence concerns the gene TNFSF13B and Miyoshi myopathy.